Expression of Regulatory Platelet MicroRNAs in Patients with Sickle Cell Disease

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Jain, Shilpa ^a,b   Kapetanaki, Maria G ^c   Raghavachari, Nalini ^d   Woodhouse, Kimberly ^d   Yu, Guoying ^c   Barge, Suchitra ^b   Coronnello, Claudia ^e,f   Benos, Panayiotis V ^e   Kato, Gregory J ^d   Kaminski, Naftali ^c   Gladwin, Mark T ^b,e  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f RiMED Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1225 3P; MICRORNA 154; MICRORNA 329; MICRORNA 376; MICRORNA 376A; MICRORNA 409 3P; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME 14Q; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE LOCATION; GENE OVEREXPRESSION; GENOME IMPRINTING; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PBXIP1 GENE; PHF20L1 GENE; PLAGL2 GENE; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SICKLE CELL ANEMIA; THROMBOCYTE; TRANSCRIPTION REGULATION; UPREGULATION;

ADULT; AGED; ANEMIA, SICKLE CELL; BLOOD PLATELETS; CELL LINE; CHROMOSOMES, HUMAN, PAIR 14; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMIC IMPRINTING; HUMANS; HYDROXYUREA; MALE; MEGAKARYOCYTES; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE ANNOTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; TRICUSPID VALVE INSUFFICIENCY; UP-REGULATION; YOUNG ADULT;

EID: 84876077735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060932     Document Type: Article

References (65)

1. Blann AD, Marwah S, Serjeant G, Bareford D, Wright J, (2003) Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity. Blood Coagul Fibrinolysis 14: 255-259.
2. Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, et al. (2007) Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 110: 2166-2172.
3. Wun T, Paglieroni T, Rangaswami A, Franklin PH, Welborn J, et al. (1998) Platelet activation in patients with sickle cell disease. Br J Haematol 100: 741-749.
4. Tomer A, Harker LA, Kasey S, Eckman JR, (2001) Thrombogenesis in sickle cell disease. J Lab Clin Med 137: 398-407.
5. Mohan JS, Lip GY, Bareford D, Blann AD, (2006) Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype. Thromb Res 117: 623-629.
6. Browne PV, Mosher DF, Steinberg MH, Hebbel RP, (1996) Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. Am J Hematol 51: 296-301.
7. Novelli EM, Kato GJ, Ragni MV, Zhang Y, Hildesheim ME, et al. (2012) Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates. Am J Hematol 87: 326-330.
8. Lee SP, Ataga KI, Orringer EP, Phillips DR, Parise LV, (2006) Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation. Arterioscler Thromb Vasc Biol 26: 1626-1631.
9. Antonucci R, Walker R, Herion J, Orringer E, (1990) Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets. Am J Hematol 34: 44-48.
10. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM, (1993) Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 81: 2137-2143.
11. Ross R, Glomset J, Kariya B, Harker L, (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 71: 1207-1210.
12. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, et al. (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115: 2811-2821.
13. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, et al. (2006) Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 113: 2278-2284.
14. Gnatenko DV, Cupit LD, Huang EC, Dhundale A, Perrotta PL, et al. (2005) Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype. Thromb Haemost 94: 412-421.
15. Lood C, Amisten S, Gullstrand B, Jonsen A, Allhorn M,et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood 116: 1951-1957.
16. Raghavachari N, Xu X, Harris A, Villagra J, Logun C, et al. (2007) Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 115: 1551-1562.
17. Ambros V, (2008) The evolution of our thinking about microRNAs. Nat Med 14: 1036-1040.
18. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
19. Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, et al. (2006) MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A 103: 5078-5083.
20. Masaki S, Ohtsuka R, Abe Y, Muta K, Umemura T, (2007) Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Commun 364: 509-514.
21. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT, (2007) Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 35: 1657-1667.
22. Rossi S, Shimizu M, Barbarotto E, Nicoloso MS, Dimitri F,et al. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood 116: 945-952.
23. Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, et al. (2009) Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 114: 3872-3879.
24. Kannan M, Mohan KV, Kulkarni S, Atreya C, (2009) Membrane array-based differential profiling of platelets during storage for 52 miRNAs associated with apoptosis. Transfusion 49: 1443-1450.
25. Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, et al. (2009) Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 16: 961-966.
26. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694.
27. Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, et al. (2011) Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 117: 5189-5197.
28. Kondkar AA, Bray MS, Leal SM, Nagalla S, Liu DJ, et al. (2010) VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost 8: 369-378.
29. Osman A, Falker K, (2011) Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 22: 433-441.
30. Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, et al. (2012) Profibrotic Role of miR-154 in Pulmonary Fibrosis. Am J Respir Cell Mol Biol.
31. Konishi K, Gibson KF, Lindell KO, Richards TJ, Zhang Y, et al. (2009) Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 180: 167-175.
32. Saldanha AJ, (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248.
33. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
34. Betel D, Wilson M, Gabow A, Marks DS, Sander C, (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36: D149-153.
35. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
36. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA, (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70.
37. Coronnello C HR, Arora A, Huleihel L, Pandit KV, et al. (2012) Novel modeling of combinatorial miRNA targeting identifies SNP with potential role in bone density. PLoS Comput Biol accepted.
38. Betel D, Koppal A, Agius P, Sander C, Leslie C, (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11: R90.
39. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284.
40. Amisten S, (2012) A rapid and efficient platelet purification protocol for platelet gene expression studies. Methods Mol Biol 788: 155-172.
41. Schedel A, Rolf N, (2009) Genome-wide platelet RNA profiling in clinical samples. Methods Mol Biol 496: 273-283.
42. Kaushansky K, (2005) The molecular mechanisms that control thrombopoiesis. J Clin Invest 115: 3339-3347.
43. Queen LR, Ferro A, (2006) Beta-adrenergic receptors and nitric oxide generation in the cardiovascular system. Cell Mol Life Sci 63: 1070-1083.
44. Smolenski A, (2012) Novel roles of cAMP/cGMP-dependent signaling in platelets. J Thromb Haemost 10: 167-176.
45. Hers I, (2007) Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway. Blood 110: 4243-4252.
46. Kim S, Garcia A, Jackson SP, Kunapuli SP, (2007) Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform. Blood 110: 4206-4213.
47. Jison ML, Munson PJ, Barb JJ, Suffredini AF, Talwar S, et al. (2004) Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 104: 270-280.
48. Abdollahi A, (2007) LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions. J Cell Physiol 210: 16-25.
49. Ammons MC, Siemsen DW, Nelson-Overton LK, Quinn MT, Gauss KA, (2007) Binding of pleomorphic adenoma gene-like 2 to the tumor necrosis factor (TNF)-alpha-responsive region of the NCF2 promoter regulates p67(phox) expression and NADPH oxidase activity. J Biol Chem 282: 17941-17952.
50. Mendjan S, Taipale M, Kind J, Holz H, Gebhardt P, et al. (2006) Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. Mol Cell 21: 811-823.
51. Badeaux AI, Yang Y, Cardenas K, Vemulapalli V, Chen K, et al. (2012) Loss of the methyl lysine effector protein PHF20 impacts the expression of genes regulated by the lysine acetyltransferase MOF. J Biol Chem 287: 429-437.
52. Benetatos L, Hatzimichael E, Londin E, Vartholomatos G, Loher P, et al. (2012) The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol Life Sci.
53. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, et al. (2004) A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 14: 1741-1748.
54. Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, et al. (2008) Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 3: e2141.
55. Steele BM, Harper MT, Macaulay IC, Morrell CN, Perez-Tamayo A, et al. (2009) Canonical Wnt signaling negatively regulates platelet function. Proc Natl Acad Sci U S A 106: 19836-19841.
56. Toma I, McCaffrey TA, (2012) Transforming growth factor-beta and atherosclerosis: interwoven atherogenic and atheroprotective aspects. Cell Tissue Res 347: 155-175.
57. Bazzoni G, (2011) Pathobiology of junctional adhesion molecules. Antioxid Redox Signal 15: 1221-1234.
58. Nachman RL, Rafii S, (2008) Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 359: 1261-1270.
59. Chavda N, Mackie IJ, Porter JB, Harrison P, Patterson K, et al. (1996) Rapid flow cytometric quantitation of reticulated platelets in whole blood. Platelets 7: 189-194.
60. Freedman ML, Karpatkin S, (1975) Elevated platelet count and megathrombocyte number in sickle cell anemia. Blood 46: 579-582.
61. Noronha JF, Costa FF, Saad ST, Lorand-Metze IG, Grotto HZ, (2007) Evaluation of reticulated platelets in patients with sickle cell diseases. Thromb Res 121: 259-267.
62. Popescu ER, Martelo OJ, (1977) Megathrombocytes and sickle cell anemia. Blood 49: 490-491.
63. Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, et al. (2001) Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85: 639-646.
64. Horstman LL, Ahn YS, (1999) Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 30: 111-142.
65. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, et al. (2001) Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 85: 810-820.